Orthopediatrics (KIDS) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Orthopediatrics (KIDS) Net Income towards Common Stockholders Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 12.92% |
| 10 | Orthopediatrics | 633.92 Mn | 588.04 Mn | 52.37 Mn | -0.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.70% |
| Mar 31, 2026 | -0.26% |
| Dec 31, 2025 | 37.13% |
| Sep 30, 2025 | -48.67% |
| Jun 30, 2025 | -17.98% |
| Mar 31, 2025 | -36.57% |
| Dec 31, 2024 | -140.16% |
| Sep 30, 2024 | -72.49% |
| Jun 30, 2024 | -108.91% |
| Mar 31, 2024 | -14.68% |
| Dec 31, 2023 | 14.74% |
| Sep 30, 2023 | -124.76% |
| Jun 30, 2023 | -766.67% |
| Mar 31, 2023 | 25.21% |
| Dec 31, 2022 | -11,000.00% |
| Sep 30, 2022 | 943.83% |
| Jun 30, 2022 | 91.13% |
| Mar 31, 2022 | 12.32% |
| Dec 31, 2021 | 100.51% |
| Sep 30, 2021 | 51.60% |